| scholarly article | Q13442814 |
| P50 | author | Jacqueline C M Witteman | Q105980953 |
| Cornelia M. van Duijn | Q28321102 | ||
| Albert Hofman | Q30121906 | ||
| Christine Van Broeckhoven | Q2247235 | ||
| P2093 | author name string | Bronzova J | |
| Slooter AJ | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| estrogen | Q277954 | ||
| P304 | page(s) | 779-781 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
| P1476 | title | Estrogen use and early onset Alzheimer's disease: a population-based study | |
| P478 | volume | 67 |
| Q36202424 | Blood glutamate scavenging: insight into neuroprotection |
| Q34997783 | Brain aging and Alzheimer's disease; use it or lose it. |
| Q35241461 | Brain to blood glutamate scavenging as a novel therapeutic modality: a review |
| Q30634935 | Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies |
| Q34777681 | Dementia epidemiology |
| Q44368386 | Effect of 17 beta-estradiol on gene expression in lumbar spinal cord following sciatic nerve crush injury in ovariectomized mice |
| Q34708147 | Estrogen actions in the brain |
| Q34767487 | Estrogen and Alzheimer's disease: the story so far. |
| Q35109605 | Estrogen and Cognitive Functioning in Women |
| Q48269425 | Estrogen and brain vulnerability |
| Q28217161 | Estrogen lowers Alzheimer beta-amyloid generation by stimulating trans-Golgi network vesicle biogenesis |
| Q24796371 | Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine |
| Q36202013 | Estrogen receptor beta in health and disease |
| Q44296107 | Homocysteine, white matter hyperintensities, and cognition in healthy elderly people |
| Q48206860 | Increased neuronal metabolic activity and estrogen receptors in the vertical limb of the diagonal band of Broca in Alzheimer's disease: relation to sex and aging |
| Q60542576 | Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection |
| Q34365355 | Iron overload, oxidative stress, and axonal dystrophy in brain disorders |
| Q40238961 | Meta-analyses of the effect of hormone treatment on cognitive function in postmenopausal women. |
| Q37003047 | Modulation of alphaCaMKII signaling by rapid ERalpha action |
| Q93080626 | Molecular Inverse Comorbidity between Alzheimer's Disease and Lung Cancer: New Insights from Matrix Factorization |
| Q34495105 | Morphological abnormalities in the brains of estrogen receptor beta knockout mice |
| Q34065270 | Neuroprotection by estradiol. |
| Q34664961 | Oestrogen as a neuroprotective hormone |
| Q34074827 | Ongoing trials in Alzheimer's disease |
| Q30708039 | Prevalence of dementia in users of hormone replacement therapy as defined by prescription data |
| Q36436653 | Prognostic factors in paediatric anaplastic large cell lymphoma: role of ALK. |
| Q36176965 | Sex, hormones, and Alzheimer's disease |
| Q90637954 | The Effect of Estrogen Replacement Therapy on Alzheimer's Disease and Parkinson's Disease in Postmenopausal Women: A Meta-Analysis |
| Q34951934 | The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review |
| Q34116506 | The interface between pharmacoepidemiology and pharmacogenetics |
| Q35134604 | The menopause and HRT. HRT and cognitive decline |
| Q40735061 | The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. |
| Q33645788 | Thyroid medication use and subsequent development of dementia of the Alzheimer type |
| Q38653824 | What is the role of modifiable environmental and lifestyle risk factors in young onset dementia? |
| Q44633556 | β-estradiol influences differentiation of hippocampal neurons in vitro through an estrogen receptor-mediated process |
Search more.